Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dag Harald Skutlaberg

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristicsSverre Rørtveit, Dag Harald Skutlaberg, Nina Langeland, et al.
Scandinavian Journal of Infectious Diseases|September 18, 2014
The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western NorwaySverre Rørtveit, Dag Harald Skutlaberg, Nina Langeland, et al.
Military Medicine|October 24, 2002
The interaction between military education and health: a survey among conscripts undergoing officer training in NorwayArne Johan Norheim, Dag Harald Skutlaberg, Jens Harald Holmboe, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 7, 2016
Extended spectrum cephalosporin resistance among clinical isolates of Enterobacteriaceae in West Norway during 2006-2013; a prospective surveillance studyHaima Mylvaganam, Helge Kolstad, Rebecca Irene Breistein, et al.
Frontiers in Microbiology|March 7, 2022
Consistent Biofilm Formation by <i>Streptococcus pyogenes emm 1</i> Isolated From Patients With Necrotizing Soft Tissue InfectionsDag Harald Skutlaberg, Harald G Wiker, Haima Mylvaganam, et al.
Antibiotics (Basel, Switzerland)|April 3, 2021
Carbapenem-Resistant Enterobacteriaceae-Implications for Treating Acute Leukemias, a Subgroup of Hematological MalignanciesKristin Ølfarnes Storhaug, Dag Harald Skutlaberg, Bent Are Hansen, et al.
Emerging Infectious Diseases|January 24, 2023
Streptococcus dysgalactiae Bloodstream Infections, Norway, 1999-2021Oddvar Oppegaard, Marte Glambek, Dag Harald Skutlaberg, et al.
Pathogens (Basel, Switzerland)|April 26, 2024
Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective AnalysisBiplob Kumar Mohanty, Tomas Mikal Lind Eagan, Bernt Bøgvald Aarli, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2009
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and SwedenØrjan Samuelsen, Umaer Naseer, Ståle Tofteland, et al.
BMC Infectious Diseases|February 17, 2017
Zoonotic necrotizing myositis caused by Streptococcus equi subsp. zooepidemicus in a farmerBård Reiakvam Kittang, Veronika Kuchařová Pettersen, Oddvar Oppegaard, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristicsSverre Rørtveit, Dag Harald Skutlaberg, Nina Langeland, et al.
Scandinavian Journal of Infectious Diseases|September 18, 2014
The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western NorwaySverre Rørtveit, Dag Harald Skutlaberg, Nina Langeland, et al.
Military Medicine|October 24, 2002
The interaction between military education and health: a survey among conscripts undergoing officer training in NorwayArne Johan Norheim, Dag Harald Skutlaberg, Jens Harald Holmboe, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 7, 2016
Extended spectrum cephalosporin resistance among clinical isolates of Enterobacteriaceae in West Norway during 2006-2013; a prospective surveillance studyHaima Mylvaganam, Helge Kolstad, Rebecca Irene Breistein, et al.
Frontiers in Microbiology|March 7, 2022
Consistent Biofilm Formation by <i>Streptococcus pyogenes emm 1</i> Isolated From Patients With Necrotizing Soft Tissue InfectionsDag Harald Skutlaberg, Harald G Wiker, Haima Mylvaganam, et al.
Antibiotics (Basel, Switzerland)|April 3, 2021
Carbapenem-Resistant Enterobacteriaceae-Implications for Treating Acute Leukemias, a Subgroup of Hematological MalignanciesKristin Ølfarnes Storhaug, Dag Harald Skutlaberg, Bent Are Hansen, et al.
Emerging Infectious Diseases|January 24, 2023
Streptococcus dysgalactiae Bloodstream Infections, Norway, 1999-2021Oddvar Oppegaard, Marte Glambek, Dag Harald Skutlaberg, et al.
Pathogens (Basel, Switzerland)|April 26, 2024
Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective AnalysisBiplob Kumar Mohanty, Tomas Mikal Lind Eagan, Bernt Bøgvald Aarli, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2009
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and SwedenØrjan Samuelsen, Umaer Naseer, Ståle Tofteland, et al.
BMC Infectious Diseases|February 17, 2017
Zoonotic necrotizing myositis caused by Streptococcus equi subsp. zooepidemicus in a farmerBård Reiakvam Kittang, Veronika Kuchařová Pettersen, Oddvar Oppegaard, et al.
Pageof 2